Triton Acquires Majority Stake in Atnahs
August 8, 2019
Funds advised by Triton Partners have acquired a majority stake in Atnahs, a UK-based specialty pharmaceutical business that acquires, develops and markets mature branded medicines. Atnahs operates a portfolio of over 800 SKUs across more than 130 markets; terms of the transaction were not disclosed.
- Targets
- Atnahs
- Industry
- Pharmaceuticals
- Location
- Essex, United Kingdom
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Abenex Acquires Majority Stake in Tethys
May 1, 2026
Industrial Services
Abenex announced the acquisition of a majority stake in Tethys, a French specialist in pyromechanical systems for critical applications. The transaction makes Abenex the majority shareholder alongside the management team, with Bpifrance reinvesting as part of the deal.
-
Hale Capital Partners Acquires Majority Stake in Athenium
November 6, 2024
Software
Hale Capital Partners, a New York-based growth private equity firm, led a cooperative recapitalization to acquire a majority stake in Athenium, a Dover, New Hampshire provider of risk and quality management software. The investment brings in Jim Greenwell as CEO and will support product development, AI/analytics capabilities and expansion into new verticals including insurance, financial services and government.
-
Parthenon Capital Acquires Majority Stake in Titan Wealth
February 21, 2023
Wealth Management
Parthenon Capital has acquired a majority stake in Titan Wealth, partnering with the management team to support further organic growth, technology investment and future M&A. The transaction delivers a partial exit for Maven's UK Regional Buyout Fund (with a material return) while existing investors including funds managed by Ares and Maven remain committed to the business.
-
Partners Group Acquires Pharmathen from BC Partners
July 19, 2021
Pharmaceuticals
Partners Group has agreed to acquire Pharmathen, the leading European drug delivery technology and pharmaceutical manufacturing company, from BC Partners in a transaction valued at approximately EUR 1.6 billion. The deal transfers control of Pharmathen to Partners Group (acting on behalf of its clients) and is aimed at supporting the company’s continued growth — including an intensified push into the US market — building on strong R&D and manufacturing capabilities.
-
Triton (via Trisall AB) Acquires HiQ International AB
October 22, 2020
IT Services
Triton Fund V, through its acquisition vehicle Trisall AB, acquired a controlling stake in Stockholm-based digital transformation and custom software firm HiQ International AB via a public tender offer at SEK 72 per share and has initiated compulsory acquisition of remaining shares with plans to de-list HiQ from Nasdaq Stockholm. The transaction gives Triton ownership of approximately 91% of HiQ and is positioned as a platform acquisition to invest in HiQ's growth and expand its position as a Northern European leader in digital services.
-
Triton Acquires Aleris from Patricia Industries (Investor AB)
July 12, 2019
Healthcare Services
Funds advised by Triton have acquired the majority of Aleris (Aleris Healthcare AB and Aleris Imaging AB) from Patricia Industries (part of Investor AB) in a completed divestiture. Aleris, headquartered in Stockholm with more than 3,000 employees and ~100 facilities across Scandinavia, provides specialty care, radiology and diagnostics and will be developed further by Triton as part of its Nordic healthcare platform.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.